Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7282131 | 0.79 | TSHR (0.33) | TSHRMAPK1 | |
| SCHEMBL4631571 | 0.77 | ALDH1A1 (0.35) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL5608381 | 0.74 | FFAR3 (0.35) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL7122582 | 0.74 | ALDH1A1 (0.35) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL4557462 | 0.72 | TSHR (0.32) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL10822936 | 0.72 | ALDH1A1 (0.43) | TSHRMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10822937 | 0.72 | FFAR3 (0.33) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL11301434 | 0.72 | ALDH1A1 (0.32) | TSHRMAPK1ALDH1A1 | |
| SCHEMBL3257895 | 0.70 | FFAR3 (0.32) | TSHRMAPK1ALDH1A1 | |
| Zinc Ion SCHEMBL15136365 | 0.70 | FFAR3 (0.32) | TSHRMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209480-A1 | CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2009-08-20 | — | — | US | disclosed |
| EP-0928340-A1 | INVASION-INDUCING AGENTS AND INVASION-INHIBITORS FOR USE IN WOUND HEALING AND CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1999-07-14 | — | — | EP | disclosed |
| WO-1998022617-A1 | INVASION-INDUCING AGENTS AND INVASION-INHIBITORS FOR USE IN WOUND HEALING AND CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209480-A1 | CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS | INA, BDNF, PMP22 | TSHR 3061/4885MAPK1 3744/4885ALDH1A1 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.